SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT
The invention generally relates to systems and methods for providing precision targeting and comprehensive treatment of specific tissue(s) of interest within a nasal region of a patient to undergo therapeutic treatment while minimizing or avoiding unintended collateral damage to surrounding or adjacent non-targeted tissue.
1 . A method for treating a condition within a sino-nasal cavity of a patient, the method comprising:
delivering treatment energy to tissue at a target site within a sino-nasal cavity of the patient based, at least in part, on a pulsed energy treatment pattern sufficient to maintain a consistent temperature of targeted tissue receiving the treatment energy to thereby cause ablation and/or modulation of targeted tissue for the treatment of a nasal condition,
wherein delivery of energy based on the pulsed energy treatment pattern results in ablation and/or modulation of targeted tissue sufficient to treat the nasal condition while minimizing or preventing collateral damage to non-targeted tissue at the target site.
2 . The method of claim 1 , wherein
the treatment energy is delivered via one or more electrodes of an end effector and supplied thereto from a controller operably associated with the end effector and based, at least in part, on the pulsed energy treatment pattern; and
the pulsed energy treatment pattern is determined based, at least in part, on processing, via the controller, identifying data received from the end effector associated with tissue at the target site, wherein the identifying data is associated with one or more properties of the one or more tissues, the one or more properties comprising at least one of a type, a depth, and a location of each of the one or more tissues.
3 . (canceled)
4 . (canceled)
5 . The method of claim 2 , wherein a subset of the one or more electrodes is configured to deliver non-therapeutic stimulating energy at a frequency/waveform to respective positions at the one or more target sites to thereby sense at least one of physiological properties, bioelectric properties, and thermal properties of the one or more tissues at the target site.
6 . The method of claim 5 , wherein the processing of the identifying data, via the controller, comprises correlating the identifying data received from the device with electric signature data associated with a plurality of known tissue types from a supervised and/or an unsupervised trained neural network.
7 . (canceled)
8 . The method of claim 2 , wherein the pulsed energy treatment pattern comprises data associated with at least one of a predetermined treatment time, a level of energy to be delivered from the electrodes, and a predetermined temperature range.
9 . The method of claim 8 , wherein the treatment energy is delivered based, at least in part, on processing, via the controller, of real-time feedback data associated with the one or more tissues upon supplying treatment energy thereto, wherein the feedback data comprises at least one of temperature measurement data associated with the targeted tissue, a level of energy delivered, and an elapsed delivery time.
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . The method of claim 9 , wherein the controller is configured to process the feedback data using an algorithm to determine efficacy of ablation/modulation of the targeted tissue based, at least in part, on a comparison of the feedback data with pulsed energy treatment pattern data.
14 . (canceled)
15 . The method of claim 13 , wherein delivery of treatment energy to the targeted tissue comprises delivering pulsed energy from one or more electrodes at a level and an associated duty cycle sufficient to regulate and maintain temperature of the targeted tissue receiving the treatment energy at approximately 60° C. with a tolerance of approximately ±0.2° C.
16 . (canceled)
17 . The method of claim 1 , wherein the treatment energy delivered disrupts multiple neural signals to, and/or results in local hypoxia of, mucus producing and/or mucosal engorgement elements, thereby reducing production of mucus and/or mucosal engorgement within a nose of the patient and reducing or eliminating one or more symptoms associated with the rhinosinusitis.
18 . (canceled)
19 . (canceled)
20 . The method of claim 17 , wherein targeted tissue is associated with one or more target sites proximate or inferior to a sphenopalatine foramen, wherein energy is delivered at a level sufficient to ablate targeted tissue to thereby cause thrombus formation within one or more blood vessels associated with mucus producing and/or mucosal engorgement elements within the nose, wherein the resulting local hypoxia of the mucus producing and/or mucosal engorgement elements results in decreased mucosal engorgement to thereby increase volumetric flow through a nasal passage of the patient.
21 . A system for treating a condition within a sino-nasal cavity of a patient, the system comprising:
a treatment device including an end effector comprising one or more electrodes; and
a controller operably associated with the treatment device and configured to control delivery of treatment energy from the one or more electrodes to tissue at a target site within a sino-nasal cavity of the patient based, at least in part, on a pulsed energy treatment pattern sufficient to maintain a consistent temperature of targeted tissue receiving the treatment energy to thereby cause ablation and/or modulation of targeted tissue for the treatment of a nasal condition,
wherein delivery of energy based on the pulsed energy treatment pattern results in ablation and/or modulation of targeted tissue sufficient to treat the nasal condition while minimizing or preventing collateral damage to non-targeted tissue at the target site.
22 . The system of claim 21 , wherein the controller is configured to determine the pulsed energy treatment pattern based, at least in part, on processing identifying data received from the end effector associated with tissue at the target site, wherein the identifying data is associated with one or more properties of the one or more tissues, the one or more properties comprising at least one of a type, a depth, and a location of each of the one or more tissues.
23 . (canceled)
24 . The system of claim 22 , wherein a subset of the one or more electrodes is configured to deliver non-therapeutic stimulating energy at a frequency/waveform to respective positions at the one or more target sites to thereby sense at least one of physiological properties, bioelectric properties, and thermal properties of the one or more tissues at the target site.
25 . The system of claim 24 , wherein the processing of the identifying data, via the controller, comprises correlating the identifying data received from the device with electric signature data associated with a plurality of known tissue types from a supervised and/or an unsupervised trained neural network.
26 . (canceled)
27 . The system of claim 21 , wherein the pulsed energy treatment pattern comprises data associated with at least one of a predetermined treatment time, a level of energy to be delivered from the electrodes, and a predetermined temperature range.
28 . The system of claim 27 , wherein the treatment energy is delivered based, at least in part, on processing, via the controller, of real-time feedback data associated with the one or more tissues upon supplying treatment energy thereto, wherein the feedback data comprises at least one of temperature measurement data associated with the targeted tissue, a level of energy delivered, and an elapsed delivery time.
29 . (canceled)
30 . (canceled)
31 . (canceled)
32 . (canceled)
33 . The system of claim 28 , wherein the controller is configured to process the feedback data using an algorithm to determine efficacy of ablation/modulation of the targeted tissue based, at least in part, on a comparison of the feedback data with pulsed energy treatment pattern data.
34 . (canceled)
35 . The system of claim 33 , wherein delivery of treatment energy to the targeted tissue comprises delivering pulsed energy from one or more electrodes at a level and an associated duty cycle sufficient to regulate and maintain temperature of the targeted tissue receiving the treatment energy at approximately 60° C. with a tolerance of approximately ±0.2° C.
36 . (canceled)
37 . The system of claim 21 , wherein the treatment energy delivered disrupts multiple neural signals to, and/or results in local hypoxia of, mucus producing and/or mucosal engorgement elements, thereby reducing production of mucus and/or mucosal engorgement within a nose of the patient and reducing or eliminating one or more symptoms associated with the rhinosinusitis.
38 . (canceled)
39 . (canceled)
40 . The system of claim 37 , wherein targeted tissue is associated with one or more target sites proximate or inferior to a sphenopalatine foramen, wherein energy is delivered at a level sufficient to ablate targeted tissue to thereby cause thrombus formation within one or more blood vessels associated with mucus producing and/or mucosal engorgement elements within the nose, wherein the resulting local hypoxia of the mucus producing and/or mucosal engorgement elements results in decreased mucosal engorgement to thereby increase volumetric flow through a nasal passage of the patient.